<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="" /><meta name="keywords" content="Antileprotic drugs; Leprosy; Hansen's disease; Dapsone: leprosy; Rifampicin: leprosy; Lepra reactions; Prednisolone: lepra reactions; Thalidomide: lepra reactions" /><meta name="IX" content="Antileprotic drugs; Leprosy; Hansen's disease; Dapsone: leprosy; Rifampicin: leprosy; Lepra reactions; Prednisolone: lepra reactions; Thalidomide: lepra reactions" /><title>5.1.10 Antileprotic drugs: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP3638-antileprotic-drugs.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP3638-antileprotic-drugs.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP3638-antileprotic-drugs.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP3253-infections.htm">5 Infections</a> &gt; <a href="PHP3256-antibacterial-drugs.htm">5.1 Antibacterial drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP3636-streptomycin.htm" title="Previous: STREPTOMYCIN">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP3641-dapsone.htm" title="Next: DAPSONE">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1><span>5.1.10 </span>Antileprotic drugs</h1><?highlighter on?><div id="pC" class="jN"><p>Advice from a member of the Panel of Leprosy Opinion is essential for the treatment of leprosy (Hansen's disease). Details can be obtained from the Hospital for Tropical Diseases, London (telephone (020) 3456 7890).</p> <p>The World Health Organization has made recommendations to overcome the problem of dapsone resistance and to prevent the emergence of resistance to other antileprotic drugs. Drugs recommended are <strong>dapsone</strong>, <strong>rifampicin</strong> (<a title=" Antituberculous drugs" href="PHP3588-antituberculosis-drugs.htm">section 5.1.9</a>), and <strong>clofazimine</strong>. Other drugs with significant activity against <em>Mycobacterium leprae</em> include ofloxacin, minocycline and clarithromycin, but none of these are as active as rifampicin; at present they should be reserved as second-line drugs for leprosy.</p> <p>A three-drug regimen is recommended for <em>multibacillary leprosy</em> (lepromatous, borderline-lepromatous, and borderline leprosy) and a two-drug regimen for <em>paucibacillary leprosy</em> (borderline-tuberculoid, tuberculoid, and indeterminate). The following regimens are widely used throughout the world (with minor local variations):</p> <div class="table" id="PHP3639"><table class="table" cellspacing="0" cellpadding="8" border="0" style="border-collapse: collapse;"><colgroup><col /><col /></colgroup><tbody><tr><td style="" colspan="2"><em>Multibacillary leprosy (3-drug regimen)</em></td></tr><tr><td style="">Rifampicin</td><td style="">600 mg once-monthly, supervised (450 mg for adults weighing less than 35 kg)</td></tr><tr><td style="">Dapsone</td><td style="">100 mg daily, self-administered (50 mg daily or 1–2 mg/kg daily for adults weighing less than 35 kg) </td></tr><tr><td style="">Clofazimine</td><td style="">300 mg once-monthly, supervised, <em>and</em> 50 mg daily (or 100 mg on alternate days), self-administered</td></tr></tbody></table></div> <p>Multibacillary leprosy should be treated for at least 2 years. Treatment should be continued unchanged during both type I (reversal) or type II (erythema nodosum leprosum) reactions. During reversal reactions neuritic pain or weakness can herald the rapid onset of permanent nerve damage. Treatment with prednisolone (initially 40–60 mg daily) should be instituted at once. Mild type II reactions may respond to aspirin. Severe type II reactions may require corticosteroids; thalidomide [unlicensed] is also useful in men and post-menopausal women who have become corticosteroid dependent, but it should be used under <strong>specialist supervision</strong> and it should <strong>never</strong> be used in women of child-bearing potential (significant teratogenic risk—for CSM guidance on prescribing, see <em>Current Problems in Pharmacovigilance</em> 1994; <strong>20</strong>, 8). Increased doses of clofazimine 100 mg 3 times daily for the first month with subsequent reductions, are also useful but may take 4–6 weeks to attain full effect.</p> <div class="table" id="PHP3640"><table class="table" cellspacing="0" cellpadding="8" border="0" style="border-collapse: collapse;"><colgroup><col /><col /></colgroup><tbody><tr><td style="" colspan="2"><em>Paucibacillary leprosy (2-drug regimen)</em></td></tr><tr><td style="">Rifampicin</td><td style="">600 mg once-monthly, supervised (450 mg for those weighing less than 35 kg)</td></tr><tr><td style="">Dapsone</td><td style="">100 mg daily, self-administered (50 mg daily or 1–2 mg/kg daily for adults weighing less than 35 kg) </td></tr></tbody></table></div> <p>Paucibacillary leprosy should be treated for 6 months. If treatment is interrupted the regimen should be recommenced where it was left off to complete the full course.</p> <p>Neither the multibacillary nor the paucibacillary antileprosy regimen is sufficient to treat tuberculosis.</p> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_PHP3641-dapsone"><a href="PHP3641-dapsone.htm" title="DAPSONE">DAPSONE</a></li><li id="_PHP3643-clofazimine"><a href="PHP3643-clofazimine.htm" title="CLOFAZIMINE">CLOFAZIMINE</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP3636-streptomycin.htm">Previous: STREPTOMYCIN</a> | <a class="top" href="PHP3638-antileprotic-drugs.htm#">Top</a> | <a accesskey="]" href="PHP3641-dapsone.htm">Next: DAPSONE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>